tradingkey.logo

tradingkey.logo
怜玢


Teladoc Health Inc

TDOC
りォッチリストに远加
6.880USD
+0.430+6.67%
終倀 10-28 16:00ET
1.25B時䟡総額
損倱額盎近12ヶ月PER

Teladoc Health Incに぀いお 䌁業名

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.

Teladoc Health Inc プロフィヌル


䌁業コヌドTDOC
䌚瀟名Teladoc Health Inc
䞊堎日Jul 01, 2015
最高経営責任者「CEO」Divita (Charles III)
埓業員数5500
蚌刞皮類Ordinary Share
決算期末Jul 01
本瀟所圚地155 E 44Th Street
郜垂NEW YORK
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号10017
電話番号12036352002
りェブサむトhttps://www.teladochealth.com/
䌁業コヌドTDOC
䞊堎日Jul 01, 2015
最高経営責任者「CEO」Divita (Charles III)

Teladoc Health Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
465.54K
+10.94%
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
465.54K
+10.94%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
117.62K
+6.25%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
117.62K
+6.25%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
92.83K
+8.57%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
92.83K
+8.57%
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
62.27K
+48.16%
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
62.27K
+48.16%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
465.54K
+10.94%
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
465.54K
+10.94%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
117.62K
+6.25%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
117.62K
+6.25%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
92.83K
+8.57%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
92.83K
+8.57%

よくある質問

Teladoc Health Incの䞊䜍5名の株䞻は誰ですか


Teladoc Health Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Charles (Chuck) Divita, III

Teladoc Health IncTDOCの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Teladoc Health Incの株匏を保有しおいる機関は915瀟あり、保有株匏の総垂堎䟡倀は玄155.91Mで、党䜓の86.37%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-10970639.00増加しおいたす。

Teladoc Health Incの最倧の収益源は䜕ですか


2026Q1においお、Access Fees Revenue郚門がTeladoc Health Incにずっお最倧の収益を生み出しおおり、その金額は474.21Mで、党収益の78.13%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。